Bispecific Antibodies in Multiple Myeloma: A Concise Review of Current Treatments
{{output}}
The treatment landscape for multiple myeloma (MM) has evolved significantly over the years; however, the disease remains incurable. Heavily pretreated patients with refractory disease to anti-CD38 therapies, proteasome inhibitors (PIs), and immunomodulatory dr... ...